Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Evaluation, using two assessment instruments, of the American and British national guidelines for the management of sexually transmissible and genital infections

Aisling Baird A , Olufunso Olarinde A and Martin Talbot A B
+ Author Affiliations
- Author Affiliations

A Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.

B Corresponding author. Email: martin.talbot@sth.nhs.uk

Sexual Health 4(4) 255-260 https://doi.org/10.1071/SH07048
Submitted: 3 July 2007  Accepted: 14 September 2007   Published: 23 November 2007

Abstract

Background: The objective of the present study was to compare, utilising two guideline assessment instruments, six corresponding clinical practice guidelines of the British Association for Sexual Health and HIV and the Centres for Disease Control. Methods: Three raters independently assessed the recently published guidelines for gonorrhoea, chlamydial infection, early syphilis, pelvic inflammatory disease, bacterial vaginosis and HIV testing using two instruments, the Cluzeau and the AGREE (Appraisal of Guidelines for Research and Evaluation instrument). The Cluzeau scores were a simple percentage comparison; the AGREE scores were a standardised score for each guideline development domain. Differences were assessed using the Wilcoxson signed ranks test. Inter-rater variability was calculated on the Cluzeau instrument utilising the intragroup correlation method. Results: The British Association for Sexual Health and HIV guidelines scored higher than the Centres for Disease Control guidelines in many of the assessed domains. There were significant differences between the two in many of the scores (P = 0.026–0.028). Inter-rater concordance was high to very high at 0.70–0.83. Conclusions: There were often major differences in scores between the two guideline groups. It is necessary for wider discussion within the profession to consider the significance of these findings.

Additional keywords: guideline assessment instruments, national clinical management guidelines.


References


[1] WHO. Global prevalence and incidence of selected curable sexually transmitted infections. Geneva: WHO. Available online at: http://www.who.int/hiv/pub/sti/who_hiv_aids_2001.02.pdf [verified 1 October 2007].

[2] Summerskill WS . Guidelines. In DPB McGovern, RM Valori, WSM Summerskill, M Levi (eds). Key topics in evidence-based medicine. Oxford: Bios Publishing; 2001.

[3] Cluzeau F,  Littlejohns P,  Grimshaw J,  Feder G,  Moran S. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care 1999; 11 21–8.
Crossref | GoogleScholarGoogle Scholar | PubMed | [verified 10 October 2006].

[5] Vlayen J,  Aertgeerts B,  Hannes K,  Sermeus W,  Ramaerkers D. A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care 2005; 17 235–42.
Crossref | GoogleScholarGoogle Scholar | PubMed | [verified 17 August 2007].

[8] Dixon RA , Munro JF , Silcocks PB . The evidence-based medicine workbook. Oxford: Butterworth-Heinemann; 1997.

[9] Norheim OF. Healthcare rationing – are additional criteria needed for assessing evidence based clinical practice guidelines. BMJ 1999; 319 1246–9.
[verified 14 November 2006].

[13] National Institute for Health and Clinical Excellence. The guideline development process – an overview for stakeholders, the public and the NHS (3rd edn). London: NICE. Available online at: http://www.nice.org.uk/page.aspx?o=guidelinesprocess [verified 1 October 2007].